MANE
Veradermics, Incorporated
116.80$
-0.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|
| 0.00 | – | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.02 | – | – | 0.52 | 0.49 | 0.56 | 0.46 | 1.88 | |
| 0.01 | – | – | 0.06 | 0.13 | 0.24 | 0.27 | 0.67 | |
| 0.03 | – | – | 0.58 | 0.62 | 0.80 | 0.73 | 2.54 | |
| -0.03 | – | – | -0.58 | -0.62 | -0.80 | -0.73 | -2.54 | |
| 0.00 | – | – | – | 0.01 | – | – | – | |
| -0.03 | – | – | -0.57 | -0.59 | -0.73 | -0.58 | -2.29 | |
| -0.03 | – | – | -0.57 | -0.59 | -0.73 | -0.58 | -2.29 | |
| -0.03 | – | – | -0.55 | -0.57 | -0.73 | -0.73 | -2.41 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.